The data is very large and truncated. Let me scan through what was returned to identify key US names, then write the article based on what we have.
The data returned is global (universe 7 = US/Canada broad but includes global listings). The European feed (universe 10) shows names like Nintendo, Commonwealth Bank of Australia, Macquarie, Heidelberg Materials, and AB Sagax reporting today (May 8). The US/Canada feed shows many of the same plus Day One Biopharmaceuticals.
Let me scan for notable confirmed US names in the truncated data — the key names visible include companies already noted. Let me also look at what the European universe specifically pulled for confirmed names later in the week.
Based on the data returned across both calls, here are the confirmed events I can identify:
Today (May 8): Commonwealth Bank of Australia, Oversea-Chinese Banking Corp, Macquarie Group, Nintendo, AngloGold Ashanti, Heidelberg Materials, AB Sagax, Technogym, Bechtle, Arcadis, Day One Biopharmaceuticals
The data was truncated at 32 rows of 1,628+ total — I'll write from what's confirmed.
Over 1,600 companies report earnings between May 8 and May 14. The calendar is packed across every sector and region.
Today, financial giants lead the charge. Commonwealth Bank of Australia (market cap $217bn) opens its books. Oversea-Chinese Banking Corporation ($77bn) reports alongside ($64bn). Both are major Asia-Pacific bellwethers.
Gaming fans watch Nintendo today. The Japanese giant ($54bn) faces questions about Switch 2 demand and launch timing. Results could move the whole gaming sector.
In mining, AngloGold Ashanti ($51bn) reports as gold prices remain elevated. The read-through for gold miners could be significant.
European industrials are also in focus today. Heidelberg Materials ($39bn) provides a window into construction activity across Europe. Arcadis adds engineering services color.
Swedish real estate firm AB Sagax reports today too. Property investors will watch closely given ongoing rate sensitivity in Nordic markets.
In biotech, Day One Biopharmaceuticals ($2.2bn) reports today. The oncology-focused company has been building its commercial pipeline.
No confirmed IPOs were found in the database for the next seven days.
The week shapes up as a global stress test. Results from financials, miners, and tech will set the tone heading into the second half of May.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
